1. Home
  2. CERO vs DSS Comparison

CERO vs DSS Comparison

Compare CERO & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • DSS
  • Stock Information
  • Founded
  • CERO 2017
  • DSS 1984
  • Country
  • CERO United States
  • DSS United States
  • Employees
  • CERO N/A
  • DSS N/A
  • Industry
  • CERO
  • DSS Containers/Packaging
  • Sector
  • CERO
  • DSS Consumer Discretionary
  • Exchange
  • CERO Nasdaq
  • DSS Nasdaq
  • Market Cap
  • CERO 8.4M
  • DSS 7.3M
  • IPO Year
  • CERO N/A
  • DSS N/A
  • Fundamental
  • Price
  • CERO $2.06
  • DSS $0.95
  • Analyst Decision
  • CERO
  • DSS
  • Analyst Count
  • CERO 0
  • DSS 0
  • Target Price
  • CERO N/A
  • DSS N/A
  • AVG Volume (30 Days)
  • CERO 725.7K
  • DSS 19.1K
  • Earning Date
  • CERO 02-24-2025
  • DSS 03-26-2025
  • Dividend Yield
  • CERO N/A
  • DSS N/A
  • EPS Growth
  • CERO N/A
  • DSS N/A
  • EPS
  • CERO N/A
  • DSS N/A
  • Revenue
  • CERO N/A
  • DSS $25,019,000.00
  • Revenue This Year
  • CERO N/A
  • DSS N/A
  • Revenue Next Year
  • CERO N/A
  • DSS N/A
  • P/E Ratio
  • CERO N/A
  • DSS N/A
  • Revenue Growth
  • CERO N/A
  • DSS N/A
  • 52 Week Low
  • CERO $1.70
  • DSS $0.77
  • 52 Week High
  • CERO $1,095.00
  • DSS $2.30
  • Technical
  • Relative Strength Index (RSI)
  • CERO 37.15
  • DSS 56.49
  • Support Level
  • CERO $1.70
  • DSS $0.81
  • Resistance Level
  • CERO $2.22
  • DSS $0.97
  • Average True Range (ATR)
  • CERO 0.30
  • DSS 0.07
  • MACD
  • CERO 0.27
  • DSS 0.01
  • Stochastic Oscillator
  • CERO 24.32
  • DSS 81.82

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.

Share on Social Networks: